Cite
HARVARD Citation
Hu, J. et al. (2022). LRIG2 promotes glioblastoma progression by modulating innate antitumor immunity through macrophage infiltration and polarization. Journal for immunotherapy of cancer. 10 (9), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hu, J. et al. (2022). LRIG2 promotes glioblastoma progression by modulating innate antitumor immunity through macrophage infiltration and polarization. Journal for immunotherapy of cancer. 10 (9), p. . [Online].